Eli Lilly (LLY) a Albemarle Shares (ALB) are on the list of watched stocks this weekend that have shown resilience amid sell-offs and may be ready to lead the way if market conditions improve. Together with LLY and ALB shares, Dollar tree (DLTR), Cigna (CI) a World Wrestling Entertainment (WWE) completes the list of stocks that offer both some potential growth and some protection against today’s economic risks.
All stocks have rising relative strength, indicating that they are beating the S&P 500. To some extent, all stocks except Eli Lilly have fallen short of expectations for some time, but now they seem to be increasing their games.
The initial rally, which started Thursday’s rally outside the lows, and Friday’s strong progress have yet to be demonstrated the following day. But even if that were the case, investors probably wouldn’t want to put caution behind you. Recent data on CPI inflation have underlined that the Federal Reserve still has enough work to do to dampen demand without stifling economic growth.
In other words, don’t expect to switch which will re-ignite fallen favorites whose rankings are so damaged that they lack clear entry points. There is a good chance that the qualities that supported this weekend’s watch list will continue to be in demand.
Eli Lilly has won a place in the flagship IBD 50 stock list and also in the IBD Leaderboard portfolio. WWE and DLTR shares have recently joined the watchlist.
Eli Lilly Stock
Eli Lilly, which was named IBD Stock Of The Day on Wednesday, has been in a position since it easily exceeded Q1 estimates on April 28. However, the big news that day was the release of phase 3 data for her obesity drug tirzepatide, which showed that patients lost 16% -22.5% of their body weight, depending on the dose.
After gaining profit, Wells Fargo analyst Mohit Bansal raised LLY’s share price target to 305 out of 280 with the same weight. The analyst said he expects 11% revenue growth and 21% EPS growth in 2022-2027, placing Eli Lilly at the top of the biopharmaceutical companies.
LLY shares closed slightly at 291.63 on Friday, just above their 50-day mark. Eli Lilly did not take part in Friday’s big market recovery, which was led by weathered technicians. But as a defensive growth name, LLY shares have remained in the last few weeks despite massive market sell-offs.
Eli Lilly shares have a point of purchase 314.10 from a flat base within the base pattern. However, a solid shift above the 50-day threshold, breaking the declining trend line from the April 7 high, would be feasible.
Albemarle sold hard after issuing unsatisfactory profit estimates on February 16, despite soaring lithium prices. Investors seemed to be impatient due to higher costs, production restrictions and contracts at prices that were well below market levels.
But Albemarle’s repaired the ship with its Q1 earnings on May 4 thanks to renegotiated contracts. Albemarle has increased its EPS target for 2022 to $ 9.25-12.25 from $ 5.65-6.65.
While prices for other metals are falling due to a more subdued economic outlook, lithium prices seem confident, amid projected long-term shortages.
On Friday, ALB shares jumped 7.2% to 228.82. The last two sessions have seen ALB shares rebound from their 50-day line and return to their 200-day moving average.
A clean-up of the May 5 high to 243.18 could provide a speculative entry point, as it is de facto too low to be valid. A break above 248, where ALB shares have stagnated twice, including just before the unsatisfactory fourth quarter news, would offer a brighter green light.
Dollar tree warehouse
Dollar Tree is a defensive retail game that is well suited to coping with the current slowing economy with high inflation. She was also successful in coping with cost pressures and implemented her plan to increase the price of many items to $ 1.25.
However, until recently, DLTR shares were weaker in the long run, which was mostly attributed to the acquisition of Family Dollar.
However, investors appear to be gaining confidence in the Dollar Tree outlook after the company reorganized its board of directors in March and appointed former Dollar CEO Rick Dreiling as executive chairman. Following the move, Loop Capital analyst Anthony Chukumba upgraded DLTR shares to buy-out, raising his target to 200 out of 140. He wrote that Dreiling was “dusting off Dollar General.” for a family dollar.
Shares of DLTR erupted and strengthened by about 18%, but have since returned to their 50-day mark. A strong rebound over the 50-day, a break above the declining trend line, could be done. Dollar Tree shares could have a flat base in the next week.
Cigna shares lagged behind this year’s growth among managed care shares. The group performed well at lower Covid costs and medical costs in general.
However, since the acquisition of Express Scripts, a prescription benefits management company, Cigna has shown weak results in the long run.
But now Wall Street is beginning to see value. The growth in the biosimal market, which is expected next year, looks like a tailwind. Medicaid’s shrinking role could harm other insurers once the pandemic crisis ends, but Cigna could benefit from its commercial focus.
Cigna shares have created a year-round cup pattern with a handle and are now about 4% below the 270.07 point.
In early April, World Wrestling Entertainment announced that WrestleMania 38 was the most lucrative and most attended event in the company’s history, with AT & T Stadium in Dallas attended by 156,352 people in two days.
The return of live events offers some protection against the emollient consumer. After better-than-expected Q1 results on May 5, Benchmark analyst Mike Hickey said “now is the time to buy” WWE shares. He predicted that its content next year will attract several new bidders who will enter into force in 2024.
WWE shares rose 1.6% to 58.25 on Friday. The stock is 9% below the buying point of 63.81 after it found support on its 200-day line last week. However, a strong move beyond the 50-day line and breaking the trend line would offer an earlier entry point.
WWE’s flat stock base is next to several failed stocks, but its relative strength has improved to an 11-month high.
YOU MAY ALSO LIKE:
Market rebounds; But don’t go until it happens
The best growth stocks to buy and track
IBD Digital: Unlock premium IBD stock lists, tools and analysis today
When it’s time to sell your favorite stocks